Missouri Bill Would Add Psychedelics to ‘Right to Try’ Law



Missouri Republican state Rep. Michael Davis last week introduced a measure to expand the state’s Right to Try statute to include Schedule I investigational drugs, including psilocybin, MDMA, LSD, mescaline, ibogaine, and DMT. The drugs would only be available after all other treatment options have been exhausted.

The Right to Try Law, enacted in the state in 2014, allows patients with terminal illnesses to ...

Continue Reading →

Psychedelic Therapy Needs to Confront the Mystical

Kevin’s eyes were closed, but rather than the usual darkness at the back of his eyelids, he was peering through a frame and into outer space. The cosmos stretched before him. He began to think about Einstein’s theory of relativity. The equation E = mc2 appeared and he intuitively understood what it meant, more so than ever before.

The year was 2011, and Kevin was laying on ...

Continue Reading →
Ibogaine

Breaking the Chains of Suboxone Addiction

MIAMI, Feb. 19, 2021 /PRNewswire/ — Ibogaine by David Dardashti proudly announced its 10th year anniversary as a pioneering – and world-class – ibogaine treatment center that has successfully treated thousands of patients suffering from Suboxone addiction. The clinic has established a constructed set of formulas, enabling them to treat Suboxone addiction in a matter of days.

Continue Reading →
Page 1 of 63 12345...»
UA-77446339-1